Oral Cancer: Page 26

Study: Pembrolizumab shows promise as HNC treatment
By Donna Domino
A new immunotherapy drug was found to be almost twice as effective as the preferred treatment for decreasing the size of the tumors of patients with recurrent or metastatic head and neck cancer (HNC), according to a study presented at the recent meeting of the American Society for Clinical Oncology.
June 15, 2015
2015 04 20 15 39 28 178 Cancer Cell Target 200
Study: Half of oral cancer deaths due to cigarettes
By DrBicuspid.com staff writers
Almost half of the deaths caused by cancers of the oral cavity and pharynx in U.S. adults age 35 and older in 2011 were attributable to cigarette smoking, according to a multi-institution research letter published June 15 in JAMA Internal Medicine.
June 14, 2015
2015 01 26 18 01 33 455 Cigarette Smoking 200
SNMMI: PET/CT predicts survival in head and neck cancer
By Wayne Forrest
BALTIMORE - FDG-PET and FDG-PET/CT do a good job in predicting the chances of recurrence and survival for patients with head and neck cancer within two years of completing chemotherapy treatment, according to a study presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 10, 2015
2015 06 10 14 41 29 65 Baltimore Harbor 200
Week in Review: 3 tips for clear communication; chemotherapy costs for oral cancer
By Tony Edwards
June 4, 2015
Study finds chemo costly for oral cancer in elderly
By Theresa Pablos
Medicare costs for elderly patients with oral and pharyngeal cancers are significantly impacted by treatment selection, according to a new study. Chemotherapy patients cost the program $32,000 more on average over five years than those who picked alternative treatments.
June 3, 2015
2014 06 16 09 56 39 590 Cancer Center 200
Oral cancer researcher receives $200K grant
By DrBicuspid.com staff writers
The Sidney Kimmel Foundation announced that oral stem cell researcher Scott Williams, PhD, is one of 15 recipients for the 2015 Kimmel Scholar Program and will receive two-year grants totaling $200,000.
May 28, 2015
Study: Oral cancer campaign increases awareness among black men
By DrBicuspid.com staff writers
A campaign to increase awareness of oral cancer among black men resulted in more screenings for the disease in Florida's poorest counties, according to a new study in the American Journal of Public Health.
May 26, 2015
Erectile dysfunction drug shows promise for HNSCC
By Donna Domino
The little yellow pills that have boosted men's sex lives for the past decade may someday fight head and neck cancers and other diseases, according to Florida researchers. The erectile dysfunction drug tadalafil, commonly known as Cialis, can modulate the body's immune system, resulting in a new therapeutic strategy for head and neck squamous cell carcinoma (HNSCC), a new trial has shown.
May 26, 2015
2015 04 20 15 39 28 178 Cancer Cell Target 200
DrBicuspid.com Oral Cancer & Diagnostics Insider: Erectile dysfunction drug may fight HNC
By Donna Domino
May 20, 2015
Study: Follow-up, smoking, travel distance affect HNC survival
By Donna Domino
Patients with head and neck cancer (HNC) have better survival rates when they attend follow-up visits, quit smoking, have good incomes, and live close to medical centers, according to a new study.
May 13, 2015
2015 04 20 15 39 28 178 Cancer Cell Target 200
Aspen Dental donates $20K to Oral Cancer Foundation
By DrBicuspid.com staff writers
Aspen Dental announced it will be donating more than $20,200 to the Oral Cancer Foundation as part of a program that contributed $5 for each ViziLite oral cancer screening conducted at Aspen Dental practices in April.
May 10, 2015
Forward Science featured on oral cancer podcast
By DrBicuspid.com staff writers
Forward Science Technologies, developer of the OralID cancer screening device, has joined with Fortune Management for a podcast episode focused on oral cancer.
May 5, 2015
Previous Page
Page 26 of 116
Next Page